Molecular imaging of brain tumors: A bridge between clinical and molecular medicine?

被引:26
|
作者
Schaller, B. J.
Modo, M.
Buchfelder, M.
机构
[1] Univ Gottingen, Dept Neurol Surg, D-37075 Gottingen, Germany
[2] Kings Coll London, Neuroimaging Res Grp, Ctr Cellular Basis Behav, Inst Psychiat, London WC2R 2LS, England
关键词
molecular imaging; brain tumors; positron emission tomography;
D O I
10.1007/s11307-006-0069-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
As the research on cellular changes has shed invaluable light on the pathophysiology and biochemistry of brain tumors, clinical and experimental use of molecular imaging methods is expanding and allows quantitative assessment. The term molecular imaging is defined as the in vivo characterization and measurement of biologic processes at the cellular and molecular level. Molecular imaging sets forth to probe the molecular abnormalities that are the basis of disease rather than to visualize the end effects of these molecular alterations and, therefore, provides different additional biochemical or molecular information about primary brain tumors compared to histological methods "classical" neuroradiological diagnostic studies. Common clinical indications for molecular imaging contain primary brain tumor diagnosis and identification of the metabolically most active brain tumor reactions (differentiation of viable tumor tissue from necrosis), prediction of treatment response by measurement of tumor perfusion, or ischemia. The interesting key question remains not only whether the magnitude of biochemical alterations demonstrated by molecular imaging reveals prognostic value with respect to survival, but also whether it identifies early disease and differentiates benign from malignant lesions. Moreover, an early identification of treatment success or failure by molecular imaging could significantly influence patient management by providing more objective decision criteria for evaluation of specific therapeutic strategies. Specially, as molecular imaging represents a novel technology for visualizing metabolism and signal transduction to gene expression, reporter gene assays are used to trace the location and temporal level of expression of therapeutic and endogenous genes. Molecular imaging probes and drugs are being developed to image the function of targets without disturbing them and in mass amounts to modify the target's function as a drug. Molecular imaging helps to close the gap between in vitro and in vivo integrative biology of disease.
引用
收藏
页码:60 / 71
页数:12
相关论文
共 50 条
  • [41] Nuclear medicine for all the world - from molecular Imaging to molecular medicine
    Wagner, Henry N., Jr.
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (04) : 595 - 597
  • [42] Structuring an imaging core services for clinical trials in nuclear medicine/molecular imaging
    Zhang, Jun
    Sammet, Steffen
    Hall, Nathan
    O'Dell, Craig
    Teetor, Trevor
    Jacko, Richard
    Heverhagen, Johannes
    McKenney, Robert
    Knopp, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [43] Stem Cell Transplantation in Brain Tumors: A New Field for Molecular Imaging?
    Nora Sandu
    Bernhard Schaller
    Molecular Medicine, 2010, 16 : 433 - 437
  • [44] Nuclear medicine and molecular imaging
    Mansi, Luigi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1544 - 1545
  • [45] Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles
    Mehta, Arnav
    Ghaghada, Ketan
    Mukundan, Srinivasan, Jr.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2016, 24 (04) : 751 - +
  • [46] Molecular Imaging for Personalized Medicine
    Russell, James
    Tian, Jie
    Kinuya, Seigo
    Shen, Baozhong
    Li, Xiao-Feng
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [47] Molecular imaging for precision medicine
    Lu, Zheng-Rong
    Minko, Tamara
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 113 : 1 - 2
  • [48] Molecular Imaging and Precision Medicine
    Gupte, Anisha A.
    Hamilton, Dale.
    CARDIOLOGY, 2016, 133 (03) : 178 - 180
  • [49] Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics
    Saivenkat Vagvala
    Jeffrey P. Guenette
    Camilo Jaimes
    Raymond Y. Huang
    Cancer Imaging, 22
  • [50] Stem Cell Transplantation in Brain Tumors: A New Field for Molecular Imaging?
    Sandu, Nora
    Schaller, Bernhard
    MOLECULAR MEDICINE, 2010, 16 (9-10) : 433 - 437